The Australian Global Health Alliance is delighted to welcome Chemonics as its first international development managing contractor member. Chemonics’ commitment to partnership-led, evidence-based, and locally-grounded global health programming and collaborations is a natural fit with the Alliance’s own values, and we look forward to seeing them engage with the Alliance’s community, networks, and expertise […]
23 June 2021 – by Aurélia Nguyen, Managing Director, Office of the COVAX Facility COVAX’s latest supply forecast is now published. According to this latest assessment, the vaccines pillar of the ACT-Accelerator will have 1.9 billion doses available for supply by the end of 2021 and, thanks to a number of recently signed advance purchase agreements, now […]
Geneva, 18 June 2021 – The Executive Board recognized Unitaid’s leadership and agility in responding to COVID-19 and discussed new challenges and opportunities facing the organization during its 38th meeting, held virtually from 16th to 18th June. Unitaid’s board reaffirmed its commitment to its core work and explored lessons learned from the pandemic response and ways its innovative model and […]
Agreement brokered by Unitaid and CHAI under the COVID-19 Oxygen Emergency Taskforce sees two of the world’s largest medical oxygen suppliers each collaborate with these ACT-Accelerator partners on increased access in low- and middle-income countries (LMICs) Two memoranda of understanding, one with Air Liquide and another with Linde, pave the way for increased oxygen supply […]
COVAX welcomes dose sharing commitments for 870 million additional doses to support equitable access to vaccines in 2021 and 2022, with the aim to deliver at least half by the end of 2021 The G7 has committed one billion doses since the February 2021 virtual G7 Early Leaders’ Summit, including pledges made at the G20 […]
Geneva, 10 June 2021 – Unitaid has been informed by the Government of the United Kingdom that our funding from the UK has been cut from an expected £77 million in 2021 to just £6 million. This includes a deferred contribution of £33 million from 2020. While recognising that the pandemic has placed governments in an unexpected […]
US Government scheme, announced today, will see 500 million doses of the Pfizer-BioNTech vaccine distributed through the COVAX Facility Deliveries will begin in August, with 200 million to be shipped in 2021 and a further 300 million by June 2022 Geneva, 10 June 2021 – Gavi, the Vaccine Alliance, today welcomes the decision by the United States […]
MEDIA RELEASE 2 June 2021 The Australian Global Health Alliance and Pacific Friends of Global Health welcome the news that the Australian Government has pledged an additional $50 million to COVAX, the global mechanism to ensure access to safe and equitable access to COVID-19 vaccines for 92 of the world’s poorest countries. Today’s commitment […]
The Gavi COVAX AMC Summit “One World Protected” virtual event, hosted today by the Government of Japan and Gavi, the Vaccine Alliance, raised US$ 2.4 billion from nearly 40 donor governments, the private sector and foundations, exceeding the funding target and bringing the total pledged to the COVAX AMC to US$ 9.6 billion to date […]
Responding to an urgent need for doses around the world, the Government of New Zealand has pledged to transfer 1.6 million doses allocated through COVAX to lower-income economies. These doses, entirely funded by New Zealand, will go to a number of low- and middle-income countries, with the first 211,200 allocated to six economies in the […]
21 May 2021 ROME – G20 leaders and heads of international and regional organizations reaffirmed their commitment to fight pandemics and support the Access to COVID-19 Tools (ACT) Accelerator –a ground breaking collaboration of global partners to accelerate the development, production and equitable delivery of new tests, treatments, vaccines and health supplies worldwide. Meeting in Rome […]
Geneva, 13th May 2021 – Unitaid is pleased to support the new Global Initiative to end Cryptococcal Meningitis deaths by 2030, launched on May 12th 2021 by key partners in the Cryptococcal Meningitis Advocacy Group. This target will help bring renewed focus on preventing the deaths of those living with HIV. Cryptococcal Meningitis (CM) is a major […]
Geneva, 12 May 2021 – The Government of Japan yesterday announced that it will host the virtual Gavi COVAX Advance Market Commitment (AMC) Summit on June 2nd 2021. The event, co-hosted by Japanese Prime Minister H.E. Yoshihide Suga and José Manuel Barroso, Chair of the Gavi Board, will aim to secure at least US $8.3 billion for 2020-21 […]
Global Fund 45th Board Meeting Reports Continued Progress Despite COVID-19 Pandemic 12 May 2021 GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria overwhelmingly praised the continued progress of the Global Fund in the past year despite the challenges of the COVID-19 pandemic. The Board discussed how the Global Fund partnership […]
